Loading clinical trials...
Loading clinical trials...
Radicle GI Health™ 24: A Randomized, Double-Blind, Placebo-Controlled, Direct-to-Consumer Study Assessing the Impact of Health and Wellness Products on Gastrointestinal (GI) Health and Related Health Outcomes
Conditions
Interventions
Radicle GI Health Placebo Control Form 1
Radicle GI Health Active Study Product 1.1 Usage
+16 more
Locations
1
United States
Radicle Science, Inc
Del Mar, California, United States
Start Date
April 29, 2024
Primary Completion Date
June 5, 2025
Completion Date
June 5, 2025
Last Updated
October 2, 2025
NCT07257913
NCT03823742
NCT07068607
NCT07008092
NCT06315179
NCT06268964
Lead Sponsor
Radicle Science
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions